Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008.

Printable Copy

Vaccine. 2015 Feb 25;33(9):1168-75. doi: 10.1016/j.vaccine.2015.01.004. Epub 2015 Jan 15.

Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh China and India 2007-2008.

Cavallaro KF¹ Sandhu HS² Hyde TB² Johnson BW³ Fischer M³ Mayer LW⁴ Clark TA⁴ Pallansch MA⁵ Yin Z⁶ Zuo S⁷ Hadler SC⁷ Diorditsa S⁸ Hasan AS⁹Bose AS¹⁰ Dietz V²; AMES Study Group.

Abstract

BACKGROUND:

Surveillance for acute flaccid paralysis with laboratory confirmation has been a key strategy in the global polio eradication initiative and the laboratory platform established for polio testing has been expanded in many countries to include surveillance for cases of febrile rash illness to identify measles and rubella cases. Vaccine-preventable disease surveillance is essential to detect outbreaks define disease burden guide vaccination strategies and assess immunization impact. Vaccines now exist to prevent Japanese encephalitis (JE) and some etiologies of bacterial meningitis.

METHODS:

We evaluated the feasibility of expanding polio-measles surveillance and laboratory networks to detect bacterial meningitis and JE using surveillance for acute meningitis-encephalitis syndrome in Bangladesh and China and acute encephalitis syndrome in India. We developed nine syndromic surveillance performance indicators based on international surveillance guidelines and calculated scores using supervisory visit reports annual reports and case-based surveillance data.

RESULTS:

Scores variable by country and targeted disease were highest for the presence of national guidelines sustainability training availability of JE laboratory resources and effectiveness of using polio-measles networks for JE surveillance. Scores for effectiveness of building on polio-measles networks for bacterial meningitis surveillance and specimen referral were the lowest because of differences in specimens and techniques.

CONCLUSIONS:

Polio-measles surveillance and laboratory networks provided useful infrastructure for establishing syndromic surveillance and building capacity for JE diagnosis but were less applicable for bacterial meningitis. Laboratory-supported surveillance for vaccine-preventable bacterial diseases will require substantial technical and financial support to enhance local diagnostic capacity.

Published by Elsevier Ltd.